Abstract:GNE myopathy is a rare autosomal recessive disorder caused by mutations in the GNE gene, which is essential for the sialic acid biosynthesis pathway. Although over 200 GNE variants have been reported, some patients remain undiagnosed with only one heterozygous mutation. This study aims to analyse the entire GNE genomic region to identify novel mutations. Patients with clinically compatible GNE myopathy and mono-allelic mutations in the GNE gene were enrolled. The other GNE mutation was searched using a combination of Sanger sequencing, targeted next-generation sequencing (NGS), exon2 qPCR, and Nanopore long-read single-molecule sequencing (LRS). Verification of pseudoexons was performed by RT-PCR and sequencing of complementary DNA (cDNA) derived from frozen skeletal muscle tissue. Ten patients were enrolled, who exhibited typical symptoms, such as foot drop, walking difficulty, or distal weakness affecting both hands and lower legs. Three patients had idiopathic thrombocytopenia (ITP) and one had increased platelet count. The median age at onset was 33 years (25-44 years). A novel deep intronic variant (DIV), c.862+870C>T, was detected in nine patients from eight unrelated families. It was predicted by SpliceAI to create new splice donor sites and lead to pseudoexon inclusion. Splice-site strength scoring methods supported these predictions, indicating high probabilities of abnormal splicing. RT-PCR and sequencing of cDNA derived from muscle tissues revealed a 146 bp inserted fragment between GNE exon 5 and 6, which would result in a premature stop codon. RNA sequencing confirmed abnormal GNE splicing and expression, causing the inclusion of a pathogenic pseudoexon in GNE mRNA. This study identified a novel deep intronic disease-causing mutation in the GNE gene. It located at the allosteric region of the UDP-GlcNAc-2-epimerase (GNE) domain, which is also associated with ITP. Further research is necessary to better understand the molecular mechanisms underlying thrombocytopenia resulted from this mutation. The discovery of novel mutations in GNE, such as the deep intronic mutation activating pseudoexon inclusion, expanded the mutational spectrum of GNE myopathy. A modified genetic test algorithm covering the entire region of GNE gene will optimize the molecular diagnosis in the future. GNE myopathy is a rare autosomal recessive disorder caused by mutations in the GNE gene, which is essential for the sialic acid biosynthesis pathway. Although over 200 GNE variants have been reported, some patients remain undiagnosed with only one heterozygous mutation. This study aims to analyse the entire GNE genomic region to identify novel mutations. Patients with clinically compatible GNE myopathy and mono-allelic mutations in the GNE gene were enrolled. The other GNE mutation was searched using a combination of Sanger sequencing, targeted next-generation sequencing (NGS), exon2 qPCR, and Nanopore long-read single-molecule sequencing (LRS). Verification of pseudoexons was performed by RT-PCR and sequencing of complementary DNA (cDNA) derived from frozen skeletal muscle tissue. Ten patients were enrolled, who exhibited typical symptoms, such as foot drop, walking difficulty, or distal weakness affecting both hands and lower legs. Three patients had idiopathic thrombocytopenia (ITP) and one had increased platelet count. The median age at onset was 33 years (25-44 years). A novel deep intronic variant (DIV), c.862+870C>T, was detected in nine patients from eight unrelated families. It was predicted by SpliceAI to create new splice donor sites and lead to pseudoexon inclusion. Splice-site strength scoring methods supported these predictions, indicating high probabilities of abnormal splicing. RT-PCR and sequencing of cDNA derived from muscle tissues revealed a 146 bp inserted fragment between GNE exon 5 and 6, which would result in a premature stop codon. RNA sequencing confirmed abnormal GNE splicing and expression, causing the inclusion of a pathogenic pseudoexon in GNE mRNA. This study identified a novel deep intronic disease-causing mutation in the GNE gene. It located at the allosteric region of the UDP-GlcNAc-2-epimerase (GNE) domain, which is also associated with ITP. Further research is necessary to better understand the molecular mechanisms underlying thrombocytopenia resulted from this mutation. The discovery of novel mutations in GNE, such as the deep intronic mutation activating pseudoexon inclusion, expanded the mutational spectrum of GNE myopathy. A modified genetic test algorithm covering the entire region of GNE gene will optimize the molecular diagnosis in the future.

The frequent variant A57F in the GNE gene in patients from Russia has Finno-Ugric Mari origin

Mutational Spectrum and Clinical Features in 35 Unrelated Mainland Chinese Patients with GNE Myopathy

GNE Myopathy: Genotype - Phenotype Correlation and Disease Progression in an Indian Cohort

P160 A Deep Intronic Variant C.862+870c>t Correlated with GNE Myopathy and Thrombocytopenia

Novel variants and genotype-phenotype correlation in a multicentre cohort of GNE myopathy in China

Polymorphic Variants rs13155212 (T/C) and rs7704267 (G/C) in the AGGF1 Gene and Risk of Varicose Veins of the Lower Extremities in the Population of Ethnic Russians

Prevalence of the cancer-associated germline variants in Russian adults and long-living individuals: using the ACMG recommendations and computational interpreters for pathogenicity assessment

Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopenia

A Novel Mutation in GNE Gene: Clinical Characteristics and Bioinformatics Analysis

A novel variant in the GNE gene in a Malian patient presenting with distal myopathy

Global carrier frequency and predicted genetic prevalence of patients with pathogenic sequence variants in autosomal recessive genetic neuromuscular diseases

Estimating the Prevalence of GNE Myopathy Using Population Genetic Databases

Disease Progression of GNE Myopathy and Its Relationship with Genotype: A Retrospective, Observational Study in Chinese Patients.

A novel mutation alters GNE bifunctional enzyme activity and leads to familial inherited GNE diseases

Large phenotypic diversity by genotype in patients with GNE myopathy: 10 years after the establishment of a national registry in Japan

Gne Myopathy in A Chinese Male with A Novel Homozygous Mutation

Genetic Landscape of SH3TC2 variants in Russian patients with Charcot–Marie–Tooth disease

Association of maternal genetic polymorphisms with fetal growth restriction syndrome in Russian pregnant women from Rostov region

Novel Mutations in GNE Gene in Chinese Patients with Nonaka Myopathy

The Spectrum of Disease-Associated Alleles in Countries with a Predominantly Slavic Population

Polymorphisms in the MTHFR and MTR genes and the risk of varicose veins in ethnical Russians